CSI Market
Sign In | Register

Evolent Health Inc (EVH) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access EVH quarterly Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Evolent Health Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-534.51
Depreciation & amortization115.85
Amortization of Other Assets7.80
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges404.50
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation39.74
Income (Loss) from Equity Method Investments-0.37
Gains (Losses) on Extinguishment of Debt0.00
Capitalized Contract Cost Amortization6.79
Increase Decrease In Contract With Customer Asset Net-
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Accounts Receivable And Contract With Customer Asset73.70
Increase Decrease In Contract With Customer Liability-1.30
Increase Decrease In Insurance And Performance Based Arrangements Liabilities-126.51
Increase Decrease In Operating Lease Right of Use Asset-
Equity Method Investment Other Than Temporary Impairment-
Gain Loss On Disposition Of Assets Operating Activities-14.87
Gain On Transfer Of Membership-
Increase Decrease In Tax Receivable Agreement-
Changes In Tax Receivables Agreement Liability0.80
Gain Loss On Termination Of Lease Agreement15.00
Increase Decrease In Operating Lease Right Of Use Asset52.54
Increase Decrease In Capitalized Contract Cost Net-
Increase Decrease In Operating Lease Liability-
Income taxes-2.98
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities17.27
Increase (Decrease) in Accounts Payable6.64
Increase (Decrease) in Accrued Liabilities2.96
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets4.99
Other Working Capital5.03
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-34.23
Discontinued operations0.00
Net Cash flow from Operating Activities38.84
Investing Activities
Capital Expenditures-34.09
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Held-to-maturity Securities-1.00
Real Estate Investments0.00
Paymentsto Acquire Productive Assets and Businesses-
Customer Advance For Regulatory Capital Requirements-
Payments For Customer Advance For Regulatory Capital Requirements-
Proceeds From Sale And Maturity Of Investments-
Proceeds From Disposal Of Non Strategic Assets91.31
Increase (Decrease) of Restricted Investments0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-57.44
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital0.99
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Loans Receivable0.00
Payments for Removal Costs0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.23
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-342.98
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-40.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-49.86
Proceeds From Issuance Of Common Stock Net Of Payments Of Stock Issuance Costs-
Proceeds From Asset Acquisition Escrow-
Repayment And Repurchase Of Senior Debt-
Proceeds From Payments For Issuance Of Long Term Debt408.05
Payments of Ordinary Dividends, Preferred Stock and Preference Stock-11.13
Dividends paid0.00
Net Cash Flow from Financing Activities-35.92
Effect of exchange rate on cash flow-0.49
Discontinued operations0.00
Free Cash Flow4.76
Total Cash Flow2.20
4 historic quarters locked

Sign in to unlock the full Evolent Health Inc cash flow history.

Sign In Create Free Account

About Evolent Health Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: evh-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628908-26-000015

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License